BDC vs BMRN · P/E 24, rev $2.72B vs P/E 40, rev $2.85B
Belden Inc (BDC) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Belden Inc (BDC) is a communication equipment company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BDC revenue for 2025-12-31 was $2.72B. Net income was $237.5M. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. BDC currently screens at market cap $4.84B and trailing P/E 23.7.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
BDC currently screens at market cap $4.84B and trailing P/E 23.7. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the BDC and BMRN stock pages for the full models.
Not investment advice.